Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene

about

Recent tissue engineering-based advances for effective rAAV-mediated gene transfer in the musculoskeletal system.

P2860

Q38843434-25EFADA3-72DB-49FA-B9D8-7D14768B0E60

P2860

Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene

Item

http://www.wikidata.org/entity/Q37134964

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 February 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Preclinical safety evaluation ...... -immunoglobulin Fc fusion gene

@en

Preclinical safety evaluation ...... immunoglobulin Fc fusion gene.

@nl

type

Item

label

Preclinical safety evaluation ...... -immunoglobulin Fc fusion gene

@en

Preclinical safety evaluation ...... immunoglobulin Fc fusion gene.

@nl

prefLabel

Preclinical safety evaluation ...... -immunoglobulin Fc fusion gene

@en

Preclinical safety evaluation ...... immunoglobulin Fc fusion gene.

@nl

P1476

Preclinical safety evaluation ...... -immunoglobulin Fc fusion gene

@en

P2093

Aizhi Zhao

http://www.w3.org/2001/XMLSchema#string

Bo Li

http://www.w3.org/2001/XMLSchema#string

Chao Wang

http://www.w3.org/2001/XMLSchema#string

Li Liu

http://www.w3.org/2001/XMLSchema#string

Lianzhong Shen

http://www.w3.org/2001/XMLSchema#string

Weihong Qi

http://www.w3.org/2001/XMLSchema#string

Xiaobing Wu

http://www.w3.org/2001/XMLSchema#string

Xiaobing Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Preclinical safety evaluation of human gene therapy products.

The role of cytokines in the pathogenesis of rheumatoid arthritis.

Gene transfer to human joints: progress toward a gene therapy of arthritis

Effects of adeno-associated virus serotype and tissue-specific expression on circulating biomarkers of propionic acidemia.

Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer

Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method

SAFETY AND TOLERABILITY OF MRI-GUIDED INFUSION OF AAV2-hAADC INTO THE MID-BRAIN OF NON-HUMAN PRIMATE.

Intra-articular injection of recombinant TRAIL induces synovial apoptosis and reduces inflammation in a rabbit knee model of arthritis

P304

732-739

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2015.1090070

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26837862

http://www.w3.org/2001/XMLSchema#string

P921

membrane fusion involved in viral entry into host cell

vector-borne disease

P932

4964633

http://www.w3.org/2001/XMLSchema#string

Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene

about

P2860

P2860

Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932